Celltrion Healthcare starts to expand business into the Latin America
Celltrion Healthcare has started the engine to enlarge its market share in the Latin American market by signing a distribution and sales agreement of ‘Truxima(generic name: rituximab),’ a biosimilar for the treatment of hematologic malignancy, in Colombia with a global pharmaceutical company Mund...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
